Skip to main content
. 2022 Jul 15;84(4):375–383. doi: 10.1055/s-0042-1751291

Table 4. Tumor control.

Epoch Total N  = 66 1 ( N  = 20) 2 ( N  = 23) 3 ( N  = 23)
Adjuvant therapy for STR/NTR 18 (27.3%) 7 (35.0%) 5 (21.7%) 6 (26.1%) 0.62
Recurrence/Progression a 13 (22.4%) 6 (33.3%) 5 (21.7%) 2 (9.5%) 0.189
Median time to recurrence (months, range) 11 (3–172) 10 (4–172) 10 (3–52) 18 (12–24) 0.776
Treatment of recurrence/progression Ommaya reservoir 4 1 0
Intracystic P32 3 0 0
Reoperation 2 3 1
Radiotherapy (FSRT) 3 3 1
Observed 0 0 0
a

Eight patients without follow-up data.